Close Menu

NEW YORK, July 9 - GeneData has licensed its gene-function and pathway-analysis tool Phylosopher and its Expressionist microarray data-analysis tool to UK-based drug discoverer Arrow Therapeutics, the firms said today.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.